N-803: a double-edged sword in haplo-NK therapy

Blood. 2022 Feb 24;139(8):1122-1124. doi: 10.1182/blood.2021014789.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Killer Cells, Natural*
  • Recombinant Fusion Proteins

Substances

  • ALT-803
  • Recombinant Fusion Proteins